☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ripretinib
Deciphera Pharmaceuticals' Qinlock (ripretinib) Receives the US FDA's Approval to Treat 4L Gastrointestinal Stromal Tumor
May 15, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.